Instillagel (Chlorhexidine Gluconate, Lidocaine Hydrochloride)

Chlorhexidine gluconate acts as a broad‑spectrum antiseptic by binding to bacterial cell walls and disrupting membrane integrity, leading to leakage of intracellular contents and cell death. This antimicrobial activity reduces bacterial colonisation of the urethra during catheter use.

The specific amount of Instillagel to be instilled into the urethra is determined by the prescribing clinician based on the procedure and patient needs. The prescriber will specify the volume to be administered immediately before catheter insertion.

Safety data for Instillagel in pregnancy and lactation are limited. It should only be used when the potential benefit justifies any potential risk to the mother or infant, and the decision should be made by a qualified healthcare professional.

To order Instillagel, submit an enquiry on the product page at gnhindia.com, providing the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then replies with pricing, availability, shipping details and any necessary import documentation.

Unlike simple lubricants, Instillagel combines an antiseptic (chlorhexidine) with a local anaesthetic (lidocaine), offering both infection control and pain relief. Conventional lubricants provide only friction reduction, so Instillagel may provide added clinical benefits in preventing catheter‑associated infections and improving patient comfort.

Instillagel should be stored at room temperature, preferably below 25 °C, in its original sealed container. Protect the gel from direct sunlight, excessive heat and moisture. Do not freeze or expose it to extreme temperatures, and keep it out of reach of children.

Instillagel is administered by a healthcare professional who instills a prescribed volume of the gel directly into the urethra using a sterile applicator or catheter lumen, typically immediately before catheter insertion. The gel spreads along the urethral mucosa to provide antiseptic and analgesic effects.

The most serious risks include severe allergic reactions such as anaphylaxis, significant urethral inflammation or chemical cystitis, and rare cases of tissue necrosis. Immediate medical attention is required if signs of a severe reaction, such as difficulty breathing, swelling, or intense pain, occur.

Instillagel should not be used in individuals with a known hypersensitivity to chlorhexidine, lidocaine, or any component of the formulation. It is also contraindicated in patients with severe urethral injury or ulceration where the gel could exacerbate tissue damage.